摘要 |
The present invention is based, at least in part, on the discovery that the pseudogene TDGF3 (Cripto-3) is expressed in cells and, in particular, that TDGF3 overexpression is associated with transformation of a cell, e.g., TDGF3 is overexpressed in cancer cell lines and cells from tumor tissue. Accordingly, the invention provides compositions, kits, and methods for detecting the presence of a TDGF3 polynucleotide or polypeptide in a sample. The invention further provides compositions, kits and methods for assessing whether a cell is transformed as well as for assessing whether a patient is a suitable candidate for an anti-Cripto antibody therapy. |
申请人 |
BIOGEN IDEC MA INC.;OROZCO, OLIVIA;SANICOLA-NADEL, MICHELE;CHOI, EUGENE;CARULLI, JOHN;TIZARD, RICH;SZAK, SUZANNE;SUN, CHAO |
发明人 |
OROZCO, OLIVIA;SANICOLA-NADEL, MICHELE;CHOI, EUGENE;CARULLI, JOHN;TIZARD, RICH;SZAK, SUZANNE;SUN, CHAO |